The recently concluded session had traders exchanging Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) low level. Roughly 1.67 million shares changed hands compared to the three-month volume average 1.22 million shares. The first trade took place at $14.57 and the stock went up 3.71% to attain the closing price of $15.11.Ironwood Pharmaceuticals, Inc. (IRWD) Analyst Opinion
Ironwood Pharmaceuticals, Inc. has a consensus outperform rating from 11 Wall Street analysts, and the number of shares currently sold short amount to at least 12.95% of shares outstanding. The stock sank -4.79% last month and is down -1.18 this year. Wall Street is only getting more bullish on the stock, with 5 of analysts who cover IRWD having a buy-equivalent rating. Analysts have placed a $17.23 price target on Ironwood Pharmaceuticals, Inc., suggesting a 14.03% gain from recent close. It’s currently trading about -24.22% below its 52-week high.
Ironwood Pharmaceuticals, Inc. (IRWD) failed to surprise the stock market in its last reported earnings when it earned -$0.28 a piece versus the consensus-estimated -$0.22. Its revenue totaled $70.82 million up 35.75% from the previous quarter.Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Intraday View
This stock (IRWD) is ahead of its 52-week low with 21.07%. Its last month’s stock price volatility remained 4.4% which for the week stands at 3.97%. The share price has moved backward from its 20 days moving average, trading at a distance of -3.68% and stays -3.07% away from its 50 days moving average. Over the last five days, shares have managed 0.6% gains and now is down -9.21% since hitting its 200-day moving average of $16.73. Ironwood Pharmaceuticals, Inc. (IRWD) has made its way to a 12-month gain of 15.96%.
Turning to Telefonaktiebolaget LM Ericsson (publ) (NASDAQ:ERIC), its shares were trading at $6.2 a gain of $0.08, on the trading floor. The stock, after opening at $6.18, touched a high of $6.21 before paring much of its gains. So far, analysts are sticking with their neutral recommendations with the consensus call at 2.7. Telefonaktiebolaget LM Ericsson (publ) has 2 buy ratings, 6 holds and 0 sells even after the stock tumbled -17% from its high of $ 7.47 to a $20.99 billion market value through last close.
The company’s consensus rating on Reuter’s scale improved from 2.5 to 2.67 during a month. Analysts set a 12-month price target of $6.35 a share. The target implies a 2.42% spike from where the shares are currently trading. Also, the current price highlights a discount of 56.94% to analysts’ high consensus price target.Telefonaktiebolaget LM Ericsson (publ) (NASDAQ:ERIC) Intraday Trading
The counter witnessed a trading volume of 5.86 million shares versus an average volume of 5.04 million shares during last trading session. Its last month’s stock price volatility remained 1.46% which for the week approaches 1.27%. The lowest price the stock reached in the last trading day was $6.12 and compares with the $4.83 52-week low. The stock recovered 28.36% since its low point and has performed 6.35% year-to-date.